| Serial Number | 97425869 |
| Word Mark | KNACK PHARMA |
| Filing Date | Tuesday, May 24, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, June 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 25, 2023 |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of psychological disorders; Pharmaceutical preparations for the treatment and prevention of epilepsy disorders; Pharmaceutical preparations for the treatment and prevention of diabetes and diabetic neuropathy; Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases and disorders; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of pain and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of respiratory system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormone disorders and deficiencies; Pharmaceutical preparations for the treatment and prevention of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of nausea and vomiting; Pharmaceutical preparations for the treatment and prevention of AIDS-related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations for the treatment and prevention of depression; Pharmaceutical preparations for the treatment of exposure to toxic agents; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations, namely, injectable contraceptives |
| Goods and Services | Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions |
| NOT AVAILABLE | "PHARMA" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 31, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 31, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Knack Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10022 |
| Party Name | Knack Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10022 |
| Event Date | Event Description |
| Tuesday, May 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 27, 2022 | NEW APPLICATION ENTERED |
| Sunday, March 12, 2023 | ASSIGNED TO EXAMINER |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 20, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, April 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 25, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, November 13, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, December 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 19, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, June 20, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 19, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, December 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 1, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, June 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 18, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, June 18, 2024 | SOU EXTENSION 2 FILED |